DEXCOM INC Share-Based Compensation 2009-2026 | DXCM
Beta
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is DEXCOM INC's current share-based compensation?
DEXCOM INC (DXCM) annual share-based compensation for 2025 was $159.6M, a 6.34% decline from 2024. DEXCOM INC share-based compensation for the quarter ending March 31, 2026 was $43.3M.
What was DEXCOM INC's share-based compensation in 2024?
DEXCOM INC annual share-based compensation for 2024 was $170.4M, a 13.00% increase from 2023.
What was DEXCOM INC's share-based compensation in 2023?
DEXCOM INC annual share-based compensation for 2023 was $150.8M, a 19.21% increase from 2022.
What is DEXCOM INC's 5-year share-based compensation CAGR?
DEXCOM INC share-based compensation grew at a compound annual growth rate (CAGR) of 5.98% from FY2020 to FY2025, going from $119.4M to $159.6M over 5 years.
Share-Based Compensation History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+6.0%
FY2020
$119.4M
→
FY2025
$159.6M
0910111213141516171819202122232425
5 years selected
Share-Based Compensation History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $159.6M | -6.3% | 10-K |
| FY2024 | $170.4M | +13.0% | 10-K |
| FY2023 | $150.8M | +19.2% | 10-K |
| FY2022 | $126.5M | +11.6% | 10-K |
| FY2021 | $113.4M | -5.0% | 10-K |
| FY2020 | $119.4M | +16.3% | 10-K |
| FY2019 | $102.7M | +0.8% | 10-K |
| FY2018 | $101.9M | -4.0% | 10-K |
| FY2017 | $106.2M | -4.2% | 10-K |
| FY2016 | $110.8M | +34.0% | 10-K |
| FY2015 | $82.7M | +65.4% | 10-K |
| FY2014 | $50.0M | +103.3% | 10-K |
| FY2013 | $24.6M | +33.7% | 10-K |
| FY2012 | $18.4M | +36.3% | 10-K |
| FY2011 | $13.5M | +43.6% | 10-K |
| FY2010 | $9.4M | +12.4% | 10-K |
| FY2009 | $8.4M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →